Frontline Therapy Setting

Dixie-Lee Esseltine, MD, George Mulligan, PhD
Video Categories: PMO Interview with the Innovator Series: Volume 10

Dixie-Lee Esseltine, MD and George Mulligan, PhD discuss the challenges and gaps in the current standards of care of patients with multiple myeloma, including oral and intravenous treatment options in the frontline therapy setting.

March 31, 2015

Beginnings of Personalized Medicine for Myeloma

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.

April 14, 2015

CancerTYPE ID in the Clinic

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.